Work

Molecular profiling of ER+ metastatic breast cancers to reveal association of genomic alterations with acquired resistance to CDK4/6 inhibitors.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.1009

Authors: Pedram Razavi, Carlos Henrique dos Anjos, David N Brown, Li Qing, Christina Ping, Joshua Herbert, Jodecy Colon, Dazhi Liu, Maiya Mao, Larry Norton, Maurizio Scaltriti, David B. Solit, Mark E. Robson, Jorge S. Reis-Filho, Komal L. Jhaveri, Sarat Chandarlapaty

Institutions: Memorial Sloan Kettering Cancer Center, Stanford University, Albert Einstein College of Medicine

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947724245

Cites:

Cited by: 17

Related to: 10